Back home
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Contact
Our projects

Labsinlove

A New Hope for Poor-Prognosis Cancers with One-Day, Targeted Radiotherapy

Visit Website

Description

A New Hope for Poor-Prognosis Cancers with One-Day, Targeted Radiotherapy

Labsinlove is committed to transforming cancer care by advancing Boron Neutron Capture Therapy (BNCT), a cutting-edge treatment with the potential to address some of the most challenging cancers. 

Our mission focuses on leveraging innovative boron-based compounds to target cancers with poor prognosis, such as glioblastoma and recurrent head and neck cancers. At the core of our strategy is a unique combination of expertise in boron chemistry and targeted peptide technology, enabling the design and development of compounds that selectively target tumours while sparing healthy tissues. With a robust pipeline, Labsinlove is well-positioned to deliver novel solutions for advanced cancer therapy. Our approach is not only scientifically innovative but also strategically designed to address a growing unmet medical need in oncology, presenting a significant opportunity for investors and partners to join us in shaping the future of cancer treatment.

Current needs

To achieve our ambitious goals and advance our innovative BNCT therapies, Labsinlove is seeking Seed Funding. This investment will enable us to complete key regulatory steps and initiate preclinical studies to be strategically positioned to enter Phase I/II clinical trials. By addressing these near-term milestones, we will be prepare for a larger Series A funding round, which will be crucial to driving the clinical development of our pipeline.

Meet the team

Dr. Cristina Aguilera Xiol

CEO

Prof. Ignacio Porras Sánchez

CSO

José Alfonso Nebrera García

CFO

Carolina Nebrera Salcedo

Asuntos legales

Prof. Carmen Ruiz-Ruiz

Jefe de Biología

Prof. Rosario Núñez Aguilera

Jefe de Química

Actuación del Campus de excelencia cofinanciadas por la Unión Europea a través del Fondo Europeo de Desarrollo Regional (FEDER) y la Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía.

Proyecto Singular ILIBERIS: Actuaciones Singulares de Transferencia de Conocimiento en el CEI BIOTIC.

Marco por el que se impulsa el desarrollo de Proyectos Singulares de actuaciones de transferencia en los Campus de Excelencia Internacional en las áreas de la Estrategia de Investigación e Innovación para la Especialización Inteligente de Andalucía (RIS3) con cargo al Programa Operativo FEDER 2014-2020 de Andalucía.

AcexHealth